DaVita price target lowered to $154 from $157 at TD Cowen

TD Cowen lowered the firm’s price target on DaVita (DVA) to $154 from $157 and keeps a Hold rating on the shares. The firm notes the company beat consensus EBIT but reiterated FY25 guide given lower expected tx and RPT growth. Patient care cost performance and international expected to offset. The continued tepid volume growth is weighing on shares and will likely continue to be the main investor debate, but TD Cowen sees management navigating this and achieving FY25 guidance.